Article

VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway

2024-05-22

Abstract excerpt

<title>Abstract</title> <p>Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most universal liver diseases with complicated pathogenesis throughout the world. Insulin resistance is a leading risk factor that contributes to the development of NAFLD. Vascular endothelial growth factor B (VEGFB) was described by researchers as contributing to regulating lipid metabolic disorders. Here, we investiga...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8554d4f7-3295-56b4-990c-f0c5feb5b8cc
DOI: 10.21203/rs.3.rs-4341389/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathwayDOI 10.21203/rs.3.rs-4341389/v1Read

Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathwaySemantic proximity Read

Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity Read

Unraveling Berberine's Multi-Target Mechanism in Combating NAFLD: A Network Pharmacology and In Vitro StudySemantic proximity Read

Exploration of the mechanism of Alisol B in improving NAFLD of L-02 cells under hypoxic through the PI3K/AKT-mTOR-HIF1α signaling pathwaySemantic proximity Read

The role of FOXA family transcription factors in glucolipid metabolism and NAFLDSemantic proximity Read

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental studySemantic proximity Read

mmu_circ_0009303 improves nonalcoholic fatty liver disease by regulating lipid metabolism and oxidative stress in vivo and in vitroSemantic proximity Read

<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity Read

Fat Mass and Obesity–Associated Protein Promotes Liver Steatosis By Targeting PPARαSemantic proximity Read

The Role of TM6SF2 in Non-Alcoholic Fatty Liver Disease: From Mechanisms To Therapeutic StrategySemantic proximity Read

Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic studySemantic proximity Read

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing <i>PPARA</i>Semantic proximity Read